Editas Medicine Inc. Stock Performance
as on October 25, 2025 at 1:29 am IST
Day's Low
Day's High
$3.72$3.86
0.27%
Downside
3.49%
Upside
52 Week's Low
52 Week's High
$0.91$4.5475.60%
Downside
21.64%
Upside
Editas Medicine Inc. share price movements today
- Previous Close
- $3.65
- Open
- $3.75
- Volume
- 1.6M
- Day's Low - High
- $3.72 - $3.86
- 52 Week Low - High
- $0.91 - $4.54
Editas Medicine Inc. Historical Returns
- 1 Month Return
- + 8.31 %
- 3 Month Return
- + 11.96 %
- 1 Year Return
- + 14.78 %
- 3 Year Return
- -67.93 %
- 5 Year Return
- -88.86 %
Editas Medicine Inc. Stock Fundamentals & Key Indicators
Check Editas Medicine Inc. market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.
Market Cap
$321.0M
EPS (TTM)
-2.0046
Dividend Yield
0.00%
Quarterly Earnings Growth YOY
0.00%
PE Ratio (TTM)
-1.58
Industry PE ratio
-0.8798722044728434
PEG Ratio
0EBITDA
-154.1M
Revenue (TTM)
38.9M
Profit Margin
0.00%
Return On Equity TTM
-188.58%
Editas Medicine Inc. Stock Valuation
Track how Editas Medicine Inc. P/E has moved over time to understand its valuation trends.
Editas Medicine Inc. in the last 5 years
Lowest (-26.25x)
March 31, 2021
Today (-1.58x)
October 24, 2025
Industry (-0.88x)
October 24, 2025
Highest (-0.48x)
March 31, 2025
Today’s Price to Earnings Ratio: -1.58x
Editas Medicine Inc. vs Peer Comparison
Compare market cap, revenue, PE, and other key metrics of Editas Medicine Inc. with its industry peers.
Company | Analyst View | Market Cap | 5 Years Return % | PE Ratio | Profit Margin % |
|---|---|---|---|---|---|
| BUY | $321.0M | -88.86% | -1.58 | 0.00% | |
| BUY | $60.9B | 251.94% | -505.15 | -12.96% | |
| NA | $35.9B | NA | NA | -3.89% | |
| BUY | $109.3B | 99.75% | 30.31 | 31.86% | |
| BUY | $62.0B | -0.71% | 14.73 | 31.37% |
Stock Returns calculator for Editas Medicine Inc. Stock including INR - Dollar returns
The Editas Medicine Inc. stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.
*Dollar Return is the profit earned when the US dollar rises in value compared to the Indian rupee.
Investment Value
₹1,00,000
Editas Medicine Inc. investment value today
Current value as on today
₹1,21,858
Returns
₹21,858
(+21.86%)
Returns from Editas Medicine Inc. Stock
₹17,296 (+17.3%)
Dollar Returns*
₹4,562 (+4.56%)
Analyst Recommendation on Editas Medicine Inc. Stock
Based on 24 analysts
54.17%
Buy
41.67%
Hold
4.17%
Sell
Based on 24 analysts, 54.17% of analysts recommend a 'BUY' rating for Editas Medicine Inc.. Average target price of $4
Editas Medicine Inc. Share Price Target
Get share price movements and forecasts by analysts on Editas Medicine Inc..
What analysts predicted
6.75%UPSIDE
Target Price
$4
Current Price
$3.73
Analyzed by
24 Analysts
Target
$4.00
Editas Medicine Inc. target price $4, a slight upside of 6.75% compared to current price of $3.73. According to 24 analysts rating.
Editas Medicine Inc. Stock’s Investor Sentiment and Interest
Search interest for Editas Medicine Inc. Stock has increased by 41% in the last 30 days, reflecting an upward trend in search activity.
Time period: to
Change:41% versus previous 30 day period
Editas Medicine Inc. Quarterly Profit & Loss
All numbers in Millions USD
Editas Medicine Inc. Annual Profit & Loss
All numbers in Millions USD
Editas Medicine Inc. Quarterly Cash Flow
All numbers in Millions USD
Editas Medicine Inc. Annual Cash Flow
All numbers in Millions USD
Insights on Editas Medicine Inc.
Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.
POSITIVE IMPACTPrice Rise
In the last 6 months, EDIT stock has moved up by 126.7%
- POSITIVE IMPACT
Profit Spike
Netprofit is up for the last 2 quarters, -76.08M → -53.23M (in $), with an average increase of 42.9% per quarter
NO EFFECTAgainst Peers
In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 58.0% return, outperforming this stock by 43.2%
- NO EFFECT
Against Peers
In the last 3 years, Alnylam Pharmaceuticals, Inc. has given 136.9% return, outperforming this stock by 204.8%
NEGATIVE IMPACTRevenue Fall
Revenue is down for the last 3 quarters, 30.60M → 3.57M (in $), with an average decrease of 54.0% per quarter
About Editas Medicine Inc.
| Organisation | Editas Medicine Inc. |
| Headquarters | 11 Hurley Street, Cambridge, MA, United States, 02141 |
| Industry | Health Technology |
| CEO | Dr. Gilmore O'Neill M.D. |
| E-voting on shares | Click here to vote |
Key Management of Editas Medicine Inc.
Name | Title |
|---|---|
Dr. George McDonald Church Ph.D. | Co-Founder & Scientific Advisory Board Member |
Ms. Amy Parison | Senior VP & CFO |
Ms. Brieana Buckley | Senior Vice President of Development and Program Leadership |
Dr. Gilmore O'Neill M.D. | President, CEO & Director |
Dr. Feng Zhang Ph.D. | Co-Founder & Scientific Advisory Board Member |
Mr. Gregory Whitehead | Executive VP and Chief Technical & Quality Officer |
Dr. Linda C. Burkly Ph.D. | Executive VP & Chief Scientific Officer |
Cristi Barnett | Senior VP of Corporate Communications & Investor Relations |
Mr. Damien Grierson J.D. | Senior VP, General Counsel & Corporate Secretary |
Mr. Frank Panaccio | Senior VP & Chief Business Officer |
FAQs
What is Editas Medicine Inc. share price today?
Editas Medicine Inc. share price today is $3.73 as on at the close of the market. Editas Medicine Inc. share today touched a day high of $3.86 and a low of $3.72.
What is the 52 week high and 52 week low for Editas Medicine Inc. share?
Editas Medicine Inc. share touched a 52 week high of $4.54 on and a 52 week low of $0.91 on . Editas Medicine Inc. stock price today i.e. is closed at $3.73,which is 17.79% down from its 52 week high and 309.85% up from its 52 week low.
What is Editas Medicine Inc.'s market capitalisation today?
Editas Medicine Inc. market capitalisation is $0.00T as on .
How to invest in Editas Medicine Inc. Stock (EDIT) from India?
- Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
- Step 2: Search for Editas Medicine Inc. on INDmoney app. Click on Buy button. You can invest as low as $1.5 in Editas Medicine Inc. Shares that will get you 0.4021 shares as per Editas Medicine Inc. share price of $3.73 per share as on October 25, 2025 at 1:29 am IST.
What is the minimum amount required to buy Editas Medicine Inc. Stock (EDIT) from India?
Indian investors can start investing in Editas Medicine Inc. (EDIT) shares with as little as ₹87.759 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹877.59 in Editas Medicine Inc. stock (as per the Rupee-Dollar exchange rate as on ).
Based on Editas Medicine Inc. share’s latest price of $3.73 as on October 25, 2025 at 1:29 am IST, you will get 2.6810 shares of Editas Medicine Inc.. Learn more about
fractional shares .
What are the returns that Editas Medicine Inc. has given to Indian investors in the last 5 years?
Editas Medicine Inc. stock has given -88.86% share price returns and 21.02% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?